What is Eikon Therapeutics, Inc. 's short-term investments?

Eikon Therapeutics, Inc. (EIKN) reported short-term investments of $351.03M in Q1 2026.

What does short-term investments mean?

Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.

Eikon Therapeutics, Inc. EIKN Short-Term Investments

Short-Term Investments at other companies

SSR MiningSSRM

$40.27M+85.8%

RepligenRGEN

$201.88M—

UnifirstUNF

$5.66M-35.7%

Minerals TechnologiesMTX

$5.4M-3.6%

Chime Financial, Inc. Class A Common StockCHYM

$403.61M—

Syndax PharmaceuticalsSNDX

$221.17M-38.3%

Other financials

Income statement

See full

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Balance sheet

See full

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Cash flow

See full

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Valuation

See full

Market cap$514.86M—

Where this comes from

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eikon Therapeutics, Inc. 's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eikon Therapeutics, Inc. 's short-term investments?: Eikon Therapeutics, Inc. (EIKN) reported short-term investments of $351.03M in Q1 2026.
What does short-term investments mean?: Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.